Forget Vertex Pharmaceuticals -- CRISPR Therapeutics is a better buy right now.

Crispr’s ability to cut genetic code like scissors has just started to turn into medicines. Now, gene editing pioneer ...

Eli Lilly (NYSE:LLY) reported successful results from the TOGETHER-PsO Phase 3b trial combining Taltz and Zepbound for ...

Scientists have long sought to understand why some plants are fragrant powerhouses while others remain subtle. Now, a ...

Scientists are testing an entirely new way to fight heart disease: a gene-editing treatment that might offer a one-time fix ...

In this webinar, researchers discuss using and improving next-generation gene editing approaches for targeted, accurate, and ...

Eli Lilly (NYSE:LLY) reached a second milestone in its CRISPR gene editing collaboration with Scribe Therapeutics, advancing programs in neurological and neuromuscular diseases. The company reported ...

Humans have been shaping life for thousands of years through farming, breeding, and selective cultivation. But with modern tools like CRISPR, we can now directly edit DNA itself—rewriting the very ...

Faced with a life-threatening metabolic disease, KJ’s doctors at Children’s Hospital of Philadelphia sprinted to create a ...

UCLA researchers have developed a lipid nanoparticle-based gene-editing approach capable of inserting an entire healthy gene ...

Earth's biodiversity is in crisis. An imminent "sixth mass extinction" threatens beloved and important wildlife. It also threatens to reduce the amount of genetic diversity—or variation—within species ...

Scientists are testing an entirely new way to fight heart disease: a gene-editing treatment that might offer a one-time ...